As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”

Go here to see how you can start accessing these opportunities today

Omid C. Farokhzad net worth and biography

Omid Farokhzad Biography and Net Worth

of Seer

Omid Farokhzad is the Chair and Chief Executive Officer for Seer. Previously, he was Professor at Harvard Medical School and directed the Center for Nanomedicine at Brigham and Women’s Hospital. He has authored over 175 papers and is an inventor of over 200 issued and pending patents. Omid previously founded BIND Therapeutics (NASDAQ: BIND, acquired by Pfizer), Selecta Biosciences (NASDAQ: SELB), and Tarveda Therapeutics. He is a 2018 Fellow of the National Academy of Inventors. He is a recipient of the 2016 Ellis Island Medal of Honor and the 2014 Golden Door Award from the International Institute of New England, for his scientific, societal and economic contributions to America as an immigrant; the 2013 RUSNANOPRIZE, one of the largest international nanotechnology prizes for his work on nanomaterial surface modification; and the 2012 Ernst & Young New England Entrepreneur of the Year award. He received his M.D. and M.A. from Boston University and his M.B.A. from MIT Sloan School of Management.

How old is Omid C. Farokhzad?: Dr. Farokhzad is currently 55 years old. There are 1 older executives and no younger executives at Seer. The oldest executive at Seer is Mr. David R. Horn, President,Treasurer & CFO, who is 57 years old. Learn More on Omid C. Farokhzad's age.
How do I contact Omid C. Farokhzad?: The corporate mailing address for Dr. Farokhzad and other Seer executives is , , . Seer can also be reached via phone at 650-453-0000 and via email at [email protected]. Learn More on Omid C. Farokhzad's contact information.
Has Omid C. Farokhzad been buying or selling shares of Seer?: Omid C. Farokhzad has not been actively trading shares of Seer during the past quarter. Learn More on Omid C. Farokhzad's trading history.
Who are Seer's active insiders?: Seer's insider roster includes Omid Farokhzad (), David Horn (CFO), and Omead Ostadan (COO). Learn More on Seer's active insiders.
Are insiders buying or selling shares of Seer?: During the last twelve months, insiders at the sold shares 5 times. They sold a total of 89,440 shares worth more than $168,829.21. The most recent insider tranaction occured on June, 14th when Director Dipchand Nishar sold 12,109 shares worth more than $21,554.02. Insiders at Seer own 15.0% of the company. Learn More about insider trades at Seer.
Information on this page was last updated on 6/14/2024.

Omid C. Farokhzad Insider Trading History at Seer

Omid C. Farokhzad Buying and Selling Activity at Seer

Seer Company Overview

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Today's Range

Now: $2.38

$2.30

$2.43

50 Day Range

MA: $1.97

$1.64

$2.42

2 Week Range

Now: $2.38

$1.51

$2.50

Volume

86,173 shs

Average Volume

442,715 shs

Market Capitalization

$140.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.45

917 Trades… Zero Losses?

From Insiders Exposed | Ad